China Health Care Reform Plan To Favor Government-Made Drugs
This article was originally published in PharmAsia News
Executive Summary
China's new three-year health care reform guidelines include a system designed to force down the cost of prescription drugs deemed essential. The government itself is to produce and distribute essential medicines under its own control and supervision. It plans to issue a list of such drugs later this year. The number of drugs to be placed on the list has not been disclosed, but the Ministry of Health had said earlier it would be based on the 400 drugs the World Health Organization recommends be accessible. Those considered essential are based on the prevalence of a disease and the comparative cost-effectiveness of the drugs. (Click here for more)